Scinai Immunotherapeutics (SCNI) Amortizatization of Intangibles (2022 - 2026)
Scinai Immunotherapeutics' (SCNI) quarterly Amortizatization of Intangibles came in at $11000.0 in Q2 2026, up 128.21% year-over-year from $4820.2 in Q2 2025, and down 89.62% quarter-over-quarter from $106000.0 in Q1 2026.
Analysis
Scinai Immunotherapeutics (SCNI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Scinai Immunotherapeutics has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $11000.0 for Q2 2026.
- In Q2 2026, Amortizatization of Intangibles rose 128.21% year-over-year to $11000.0; the TTM figure through Jun 2026 stood at $148000.0 (up 17.46% YoY), while the FY2025 annual figure was $89000.0, down 68.66% from the prior year.
- Amortizatization of Intangibles came in at $11000.0 for Q2 2026 at Scinai Immunotherapeutics, down from $106000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $163000.0 in Q4 2022 to a low of -$39000.0 in Q2 2025.
- Average Amortizatization of Intangibles over 5 years is $49076.9, with a median of $57000.0 recorded in 2023.
- Year-over-year, Amortizatization of Intangibles jumped 5600.0% in 2024 and sank 134.21% in 2025.
- Over 5 years, Amortizatization of Intangibles stood at $163000.0 in 2022, then plunged by 65.03% to $57000.0 in 2023, then slumped by 33.33% to $38000.0 in 2024, then sank by 202.63% to -$39000.0 in 2025, then surged by 128.21% to $11000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $11000.0 in Q2 2026, $106000.0 in Q1 2026, and -$39000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 600.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.39 Mn |
| 10 | Scinai Immunotherapeutics | 1.52 Bn | 1.52 Bn | -1.25 Mn | 11,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11,000.00 |
| Mar 31, 2026 | 106,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | 70,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -18,000.00 |
| Dec 31, 2022 | 163,000.00 |